Sign up to save your podcasts
Or
Share SGLT2 Inhibitors vs. GLP-1 RAs in Diabetes, MRI Lesions After TAVR, Perioperative Management and Anticoagulants
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
SGLT2 Inhibitors vs. GLP-1 RAs in Diabetes, MRI Lesions After TAVR, Perioperative Management and Anticoagulants
In this week’s View, Dr. Eagle looks at the kidney and cardiovascular effectiveness of SGLT2 inhibitors versus GLP-1 receptor agonists in type 2 diabetes. He then explores the prognostic ability of diffusion-weighted brain MRI lesions after TAVR. Finally, Dr. Eagle discusses perioperative management of patients taking direct oral anticoagulants, particularly those being considered for noncardiac surgery.
Subscribe to Eagle’s Eye View
View all episodes
By American College of Cardiology
4.7
127127 ratings
In this week’s View, Dr. Eagle looks at the kidney and cardiovascular effectiveness of SGLT2 inhibitors versus GLP-1 receptor agonists in type 2 diabetes. He then explores the prognostic ability of diffusion-weighted brain MRI lesions after TAVR. Finally, Dr. Eagle discusses perioperative management of patients taking direct oral anticoagulants, particularly those being considered for noncardiac surgery.
Subscribe to Eagle’s Eye View
More shows like Eagle's Eye View: Your Weekly CV Update From ACC.org
View all
JAMA Editors' Summary
130 Listeners
NEJM This Week
325 Listeners
JACC Podcast
159 Listeners
This Week in Cardiology
865 Listeners
JAMA Clinical Reviews
492 Listeners
Circulation on the Run
32 Listeners
Mayo Clinic Talks
279 Listeners
JAMA Medical News
87 Listeners
Core IM | Internal Medicine Podcast
1,086 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
60 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
185 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Cardionerds: A Cardiology Podcast
423 Listeners
Mayo Clinic Cardiovascular CME
35 Listeners